Showing results (11-20 of 298) with videos related to
Sort By:
Pageof 30
Circulation|January 1, 1996
Relation between symptom duration before thrombolytic therapy and final myocardial infarct sizeM H Raitt, C Maynard, G S Wagner, et al.Journal of the American College of Cardiology|April 1, 1995
Appearance of abnormal Q waves early in the course of acute myocardial infarction: implications for efficacy of thrombolytic therapyM H Raitt, C Maynard, G S Wagner, et al.American Heart Journal|May 20, 1998
Randomized, controlled trial of RheothRx (poloxamer 188) in patients with suspected acute myocardial infarction. RheothRx in Myocardial Infarction Study GroupC Maynard, R Swenson, J A Paris, et al.The American Journal of Cardiology|September 1, 1996
Influence of early prehospital thrombolysis on mortality and event-free survival (the Myocardial Infarction Triage and Intervention [MITI] Randomized Trial). MITI Project InvestigatorsM A Brouwer, J S Martin, C Maynard, et al.Journal of the American College of Cardiology|July 21, 1998
Utility of the prehospital electrocardiogram in diagnosing acute coronary syndromes: the Myocardial Infarction Triage and Intervention (MITI) ProjectP J Kudenchuk, C Maynard, L A Cobb, et al.European Heart Journal|December 1, 1996
The role of thrombolytic drugs in the management of myocardial infarction. Comparative clinical trialsW D WeaverEuropean Heart Journal|September 1, 1996
Results of the RAPID 1 and RAPID 2 thrombolytic trials in acute myocardial infarctionW D WeaverHospital Practice (Office Ed.)|April 15, 1994
Prehospital thrombolysis in myocardial infarctionW D WeaverJournal of the American College of Cardiology|June 1, 1995
Time to thrombolytic treatment: factors affecting delay and their influence on outcomeW D WeaverPageof 30